Table 2.

Association between IL-5 and cognitive function in patients with T2DM

	Model 1				Model 2
	All		MCI		All		MCI
	R	P	R	P	R	P	R	P
MoCA	-0.389	0.000*	-0.349	0.040*	-0.399	0.000*	-0.304	0.086
DST	-0.110	0.266	-0.112	0.485	-0.092	0.357	-0.037	0.837
VFT	-0.044	0.657	-0.091	0.605	-0.037	0.710	-0.030	0.868
TMTA	0.192	0.049*	0.417	0.013*	0.203	0.039*	0.403	0.020*
TMTB	-0.182	0.063	0.179	0.302	0.204	0.039	0.173	0.337
LMT	-0.053	0.592	-0.239	0.167	-0.031	0.755	-0.166	0.356

Notes:

Model 1 showed the Pearson association between IL-5 and cognitive preference test scores in all patients and patients with MCI; Model 2 showed the partial association between IL-5 and cognitive preference test scores in all patients and patients with MCI adjusted for age and gender

*P < 0.05

Abbreviations: IL-5, interleukin-5; MCI, mild cognitive impairment; MoCA, Montreal Cognitive Assessment; DST, Digit Span Test; VFT, Verbal Fluency Test; TMTA, Trail Making Test-A; TMTB, Trail Making Test-B; LMT, Logical memory test